Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Perrigo Company has received final approval from the FDA to manufacture and market Cetirizine hydrochloride syrup, 1mg/ml.
Subscribe to our email newsletter
Perrigo’s Cetirizine syrup is comparable to McNeil Consumer Healthcare’s Zyrtec syrup, 1mg/mL, indicated for the relief of symptoms associated with seasonal allergic rhinitis.
Joseph Papa, chairman and CEO of Perrigo, said: “This approval reflects both our strategy to be first to market with important products and the unique position of the company both in front of and behind the pharmacy counter. This product will join our line of Cetirizine tablets, Cetirizine D and Cetirizine over-the-counter syrup.”